Hepatitis C Drugs: Is Next Generation the Last Generation?

被引：23

作者：

Pawlotsky, Jean-Michel ^{[1
,2
]}

机构：

[1] Univ Paris Est, Hop Henri Mondor, Natl Reference Ctr Viral Hepatitis B C&D, Dept Virol, Creteil, France

[2] INSERM, U955, Creteil, France

来源：

GASTROENTEROLOGY | 2016年 / 151卷 / 04期

关键词：

HCV GENOTYPE 1; HIGH EFFICACY; INFECTED PATIENTS; SOFOSBUVIR; RIBAVIRIN; GS-9857; ABT-493; ABT-530;

D O I：

10.1053/j.gastro.2016.08.043

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：587 / 590

页数：5

相关论文

共 19 条

[1] Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus [J].

Chung, Raymond T. ;

Davis, Gary L. ;

Jensen, Donald M. ;

Masur, Henry ;

Saag, Michael S. ;

Thomas, David L. ;

Aronsohn, Andrew I. ;

Charlton, Michael R. ;

Feld, Jordan J. ;

Fontana, Robert J. ;

Ghany, Marc G. ;

Godofsky, Eliot W. ;

Graham, Camilla S. ;

Kim, Arthur Y. ;

Kiser, Jennifer J. ;

Kottilil, Shyam ;

Marks, Kristen M. ;

Martin, Paul ;

Mitruka, Kiren ;

Morgan, Timothy R. ;

Naggie, Susanna ;

Raymond, Daniel ;

Reau, Nancy S. ;

Schooley, Robert T. ;

Sherman, Kenneth E. ;

Sulkowski, Mark S. ;

Vargas, Hugo E. ;

Ward, John W. ;

Wyles, David L. .

HEPATOLOGY, 2015, 62 (03) :932-954

[2]

Dieterich D, 2014, HEPATOLOGY, V60, p220A

[3]

Feld JJ, 2016, LIVER INT

[4]

Gane E, 2016, J HEPATOL, V64, pS758

[5] High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis [J].

Gane, Edward ;

Poordad, Fred ;

Wang, Stanley ;

Asatryan, Armen ;

Kwo, Paul Y. ;

Lalezari, Jacob ;

Wyles, David L. ;

Hassanein, Tarek ;

Aguilar, Humberto ;

Maliakkal, Benedict ;

Liu, Ran ;

Lin, Chih-Wei ;

Ng, Teresa I. ;

Kort, Jens ;

Mensa, Federico J. .

GASTROENTEROLOGY, 2016, 151 (04) :651-+

[6] Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naive or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections [J].

Gane, Edward J. ;

Schwabe, Christian ;

Hyland, Robert H. ;

Yang, Yin ;

Svarovskaia, Evguenia ;

Stamm, Luisa M. ;

Brainard, Diana M. ;

McHutchison, John G. ;

Stedman, Catherine A. .

GASTROENTEROLOGY, 2016, 151 (03) :448-+

[7]

Jensen DM, 2014, HEPATOLOGY, V60, p219A

[8]

Kwo PY, 2015, HEPATOLOGY, V62, p337A

[9] HIGH EFFICACY OF SOFOSBUVIR/VELPATASVIR/GS-9857 WITH OR WITHOUT RIBAVIRIN FOR 12 WEEKS IN DIRECT ACTING ANTIVIRAL-EXPERIENCED PATIENTS WITH GENOTYPE 1 HCV INFECTION [J].

Lawitz, E. ;

Poordad, F. ;

Wells, J. ;

Hyland, R. H. ;

Yang, Y. ;

Dvory-Sobol, H. ;

Stamm, L. M. ;

Brainard, D. M. ;

McHutchison, J. G. ;

Landaverde, C. ;

Gutierrez, J. .

JOURNAL OF HEPATOLOGY, 2016, 64 :S146-S146

[10] HIGH EFFICACY OF SOFOSBUVIR/VELPATASVIR PLUS GS-9857 FOR 12 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1-6 HCV-INFECTED PATIENTS, INCLUDING THOSE PREVIOUSLY TREATED WITH DIRECT-ACTING ANTIVIRALS [J].

Lawitz, E. ;

Kowdley, K. ;

Curry, M. ;

Reau, N. ;

Nguyen, M. ;

Kwo, P. ;

Jacobson, I. ;

Tran, T. T. ;

Nahass, R. ;

Hinestrosa, F. ;

Herring, R., Jr. ;

Bennet, M. ;

Yang, J. C. ;

Stamm, L. M. ;

An, Di ;

Dvory-Sobol, H. ;

Brainard, D. M. ;

McHutchison, J. G. ;

Schiff, E. ;

Davis, M. ;

Etzkorn, K. ;

Chung, R. T. ;

Pound, D. ;

Rodriguez-Torres, M. ;

Reddy, K. R. ;

Younes, Z. ;

Gane, E. J. .

JOURNAL OF HEPATOLOGY, 2016, 64 :S139-S140